Publication
Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease
American Journal of Physiology-Renal Physiology 321(2):F149-F161, 2021
Østergaard MV, Secher T, Christensen M, Salinas CG, Roostalu U, Skytte JL, Rune I, Hansen HH, Jelsing J, Vrang N, Fink LN
3D imagingdb/db mouseAdeno-associated virus (AAV)-mediated gene deliveryReninAAV UNx db/db mouseTherapeutic AreaMouseTargetChronic kidney diseaseCompoundMethod/EndpointSpeciesAngiotensin converting enzyme (ACE)Body weightBlood biochemistryDiabetic kidney diseaseEmpagliflozinGlomerular filtration rate (GFR)Histopathology scoreImage analysisImmunohistochemistry (IHC)Kidney morphometryLight sheet fluorescence microscopy (LSFM)NephrectomySGLT-2LisinoprilSurgeryUrine biochemistry
Share this page
Related resources
For further information
Contact us
Gubra
Hørsholm Kongevej 11B
2970 Hørsholm
Denmark
+45 3152 2650